Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Cencora, Inc. (COR)
Standardized SEC financial data for Cencora, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001140859 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$189.89B
$213.99B
$238.59B
$262.17B
$293.96B
$321.33B
Cost of revenue
$184.70B
$207.05B
$230.29B
$253.21B
$284.05B
$309.85B
Gross profit
$5.19B
$6.94B
$8.30B
$8.96B
$9.91B
$11.48B
SG&A expense
$2.77B
$3.59B
$4.85B
$5.31B
$5.66B
$6.49B
Operating income
-$5.14B
$2.35B
$2.37B
$2.34B
$2.18B
$2.63B
EBITDA
-$4.74B
$2.86B
$3.06B
$3.30B
$3.27B
$3.68B
Interest expense
$150.7M
$170.9M
$219.8M
$271.3M
$250.1M
$356.5M
Pretax income
-$5.29B
$2.22B
$2.18B
$2.16B
$2.00B
$2.26B
Income tax
$1.89B
$677.3M
$516.5M
$428.3M
$484.7M
$690.5M
Net income
-$3.41B
$1.54B
$1.70B
$1.75B
$1.51B
$1.55B
EPS (diluted)
$-16.65
$7.39
$8.04
$8.53
$7.53
$7.96
Standardized from Cencora, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.